Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates

Pravina Kitikoon, Amy L. Vincent, Bruce H. Janke, B. Erickson, Erin L. Strait, Shan Yu, Marie R. Gramer, Eileen L. Thacker

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

A swine influenza virus (SIV) vaccine-challenge pig model was used to study the potential of a conserved matrix 2 (M2) protein vaccine alone or in combination with an inactivated H1N1-vaccine to protect against H1N1 and H1N2 viruses. The H1N1-vaccine and heterologous H1N2-challenge virus model has previously been shown to prolong fever and increase SIV-associated pneumonic lesions. The M2 vaccine in combination with the H1N1-vaccine reduced the H1N2 induced fever but not virus shedding. The M2 vaccine alone reduced respiratory signs and pneumonic lesions to levels similar to the negative control pigs following H1N2 infection. This study found that the M2 protein has potential as a vaccine for SIV-associated disease prevention. However, development of an immune response towards the major envelope HA protein was required to reduce SIV shedding.

Original languageEnglish (US)
Pages (from-to)523-531
Number of pages9
JournalVaccine
Volume28
Issue number2
DOIs
StatePublished - Dec 11 2009

Keywords

  • M2 vaccine
  • Swine influenza virus
  • Vaccine

Fingerprint Dive into the research topics of 'Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates'. Together they form a unique fingerprint.

Cite this